fluorodeoxyglucose f18 has been researched along with Diabetic Angiopathies in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayabuchi, N; Honda, A; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mizoguchi, M; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S | 1 |
| Finn, AV; Tawakol, A | 1 |
| Harada, H; Hayabuchi, N; Ikeda, H; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Mawatari, K; Mizoguchi, M; Nitta, Y; Oba, T; Tahara, A; Tahara, N; Yamagishi, S; Yasukawa, H | 1 |
| Marwick, TH; Narula, J | 1 |
| Baik, SH; Choi, DS; Choi, HY; Choi, KM; Hwang, SY; Kim, NH; Kim, S; Kim, SG; Kim, TN; Seo, JA; Yang, SJ; Yoo, HJ | 1 |
| Bucerius, J; Farkouh, ME; Fayad, ZA; Fuster, V; Machac, J; Mani, V; Moncrieff, C; Rudd, JH | 1 |
| Chubuchny, V; Di Cecco, P; Emdin, M; Ferrannini, E; Guiducci, L; Iozzo, P; Knuuti, J; Lautamäki, R; Masi, S; Morales, MA; Neglia, D; Nuutila, P; Pardini, S; Porciello, C; Salvadori, PA; Sironi, AM | 1 |
| Brink, I; Hentschel, M; Högerle, S; Mix, M; Moser, E; Nitzsche, EU; Schindler, T | 1 |
| Höpfner, S; Kessler, S; Krolak, C; Tiling, R | 1 |
| Bansilal, S; Farkouh, M; Fayad, ZA; Fuster, V; Machac, J; Myers, KS; Rafique, A; Rudd, JH | 1 |
| Burchert, W; Eckert, S; Fricke, E; Fricke, H; Horstkotte, D; Körfer, J; Lindner, O; Tschöpe, D; Weise, R | 1 |
| Bax, JJ; Cornel, JH; Elhendy, A; Heine, RJ; Huitink, JM; Raymakers, PG; Van Lingen, A; Visser, CA; Visser, FC | 1 |
| Momomura, S; Nishikawa, J; Ohtake, T; Omata, M; Sasaki, Y; Yamada, N; Yokoyama, I; Yonekura, K | 1 |
| Baum, RP; Hertel, A; Hör, G; Schröder, O | 1 |
| Buell, U; Hellwig, D; Kaiser, HJ; Mull, M; Sabri, O; Schneider, R; Schreckenberger, M; Wagenknecht, G | 1 |
4 trial(s) available for fluorodeoxyglucose f18 and Diabetic Angiopathies
| Article | Year |
|---|---|
Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Topics: Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fluorodeoxyglucose F18; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Aortography; Biomarkers; Blood Glucose; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inflammation; Japan; Male; Middle Aged; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Regression Analysis; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Topics: Administration, Oral; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Hyperinsulinism; Hypolipidemic Agents; Infusions, Intravenous; Insulin; Male; Middle Aged; Pyrazines; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 1998 |
Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow.
Topics: Aged; Blood Glucose; Brain Chemistry; Cerebrovascular Circulation; Diabetes Mellitus; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
11 other study(ies) available for fluorodeoxyglucose f18 and Diabetic Angiopathies
| Article | Year |
|---|---|
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Aortography; Atherosclerosis; Carotid Artery Diseases; Contrast Media; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Magnetic Resonance Angiography; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Imaging of pharmacologic intervention decoding therapeutic mechanism or defining effectiveness?
Topics: Anti-Inflammatory Agents; Aortic Diseases; Aortography; Carotid Artery Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Aged; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Republic of Korea; Up-Regulation | 2012 |
Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake.
Topics: Age Factors; Aged; Analysis of Variance; Arteritis; Blood Glucose; Carotid Artery Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reference Values; Regression Analysis; Risk Assessment; Severity of Illness Index; Sex Factors | 2012 |
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2012 |
[Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Topics: Aged; Biological Transport; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Reference Values; Time Factors; Tomography, Emission-Computed | 2003 |
[Preoperative imaging of Charcot neuroarthropathy: Does the additional application of (18)F-FDG-PET make sense?].
Topics: Diabetic Angiopathies; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals | 2006 |
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
Topics: Aged; Aortic Diseases; Atherosclerosis; Carotid Artery Diseases; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Myocardial sympathetic innervation in diabetic patients with symptomatic coronary artery disease.
Topics: Age of Onset; Aged; Biological Transport; Coronary Circulation; Coronary Disease; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Glycated Hemoglobin; Heart Conduction System; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2008 |
Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
Topics: Aged; Blood Glucose; Coronary Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Male; Middle Aged; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1997 |
Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fatty Acids, Nonesterified; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Heart; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |